2 completed, 1 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Prism Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Placebo-Controlled, Double-Blind, Double Dummy Trial To Determine The Relative Effect Of Pm101 Versus Placebo And Amiodarone IV On Blood Pressure In Subjects With Stable Congestive Heart Failure amiodarone - Blood Pressure | Phase 2 | Withdrawn | Prism Pharmaceuticals | 2008-08-01 | 2017-09-11 | |
| A Trial to Determine the Relative Effect of PM101 I.V. Versus Placebo on Hemodynamics in Healthy Adult Volunteers PM10 - Healthy | Phase 1 | Completed | Prism Pharmaceuticals | 342 | 2007-07-03 | 2017-09-08 |
| Relative Bioavailability of PM101 IV and Cordarone IV Cordarone - Healthy | Phase 1 | Completed | Prism Pharmaceuticals | 2006-12-18 | 2017-09-08 |
Amiodarone (2)
Canada (2)